生物技术之光照耀马来西亚
开篇：润墨网以专业的文秘视角，为您筛选了一篇生物技术之光照耀马来西亚范文，如需获取更多写作素材，在线客服老师一对一协助。欢迎您的阅读与分享！
位于赤道地区的马来西亚，生物种类极其丰富，其生物多样性居世界前列。与此相较，马来西亚在生物技术方面的成就则显得黯淡无光。与生物技术发达的国家相比，马来西亚在这个领域所扮演的仅仅是低端生产者的角色，生产的大多数集中在初级产品，如胶囊或果汁，只能眼睁睁地看着其他国家在世界草药萃取领域获得大量利润。
当马来西亚热带植物公司的Rajen M.博士谈到这个问题时，他总是显得胸有成竹，他把现在的这种情况称为“贝壳现象”，沙滩上五颜六色的贝壳固然美丽，但是海里的珍珠更有价值，因为只有珍珠才照射出耀眼的光芒，这就是草本萃取技术。
根据马来西亚工业政府高科技公司调查的数据显示，按照目前每年产值超过45亿林吉特的速度，到2010年，马来西亚草本工业将翻一番。M.Rajen博士表示，凭借马来西亚所拥有的技术设备，以及在开发草本植物的巨大潜力，目前草本工业15%至20%的年增长率还会有新的提高。天时地利人和的因素，造就了马来西亚兴旺发达的生物科技产业的发展。
世界草本工业的发展
Rajen博士为我们描绘了马来西亚生物产业发展的强大基础：马来西亚拥有世界上最古老的热带雨林，生物种类资源丰富，蕴含了大量的生物潜在价值。只要通过有效的生物技术的研究和开发，这些资源就会源源不断地释放出来。但是马来西亚并不满足于低端生物技术的发展，要想进军世界生物技术产业，不但要逐渐降低对进口草本药物和医药产品的依赖，而且应该开发出新的产品和新的市场。
Rajen博士认为，马来西亚作为仅次于中国、印度、印度尼西亚，位居世界第四的草药产地，拥有着许多独特的资源。在马来西亚，中草药、印度草药和马来草药共同支撑起国家的草药工业。同时，马来西亚的多样性不仅仅体现在生物方面，还有民族性，马来西亚是世界上唯一有三个种族聚集的地方――马来人、华人和印度人。因为某种药物在某种族的人身上或许有疗效，但是在其他种族的人身上可能会有相反的效果。
但是在马来西亚，草药的疗效经过了大量的实验和研究，满足于不同种族的人群的需求。
目前，马来西亚国内草药行业每年的利润价值为40亿到50亿林吉特。到2020年，这一行业将有望占国民生产总值的5%。这说明，要提高国家经济实力，发展生物技术进行草本萃取是一条高效而迅速的道路。
全球生物技术潮流
事实上，马来西亚的生物技术风潮并不是最近才兴起的。但是随着时间的推移，生物产业在马来西亚经济中的地位不断提高，并成为国家经济发展的发动机。政府正在寻求加快生物技术发展的各种方法，如制定特殊的行业法规并创立新的管理机构，而马来西亚的教学科研机构也已经加大科研投入和基础设施的建设，以应对来自生物科技发展的新挑战。
其中，生物谷（BioValley）就是马里西亚政府的一项重要举措。与马来西亚多媒体超级走廊（Multimedia Super Corridor，简写为MSC）一样，生物谷作为生物科研机构和公司的中心，将为投资商提供良好的投资环境。马来西亚国家科学技术创新部部长Jamaludin Jarjis表示，政府或许会在税率方面采取一些吸引投资者的优惠措施。
生物技术产业的温床
私营企业将成为这个计划的主力军，为生物谷提供良好的基础设施建设。由于对生物科技产业有充足的信心，各个企业纷纷制定各自的投资计划。其中包括TH-NSTC公司负责计划在森美兰（Negeri Sembilan）的投资项目@enstek。这里面积大概有2000公顷，是一个工业和科技的中心，包括一些无污染工业如生物技术、信息通信、高级制造业等相关行业。TH公司的执行官Syed Mohamed Syed Ibrahim认为，生物技术行业对于国家经济增长有着极大的推动作用，是这些公司选择生物技术公司作为商业伙伴的原因。
热带植物 、Felda农业服务公司和Stevian生物技术公司都将入驻科技园区。热带植物公司将发展马来西亚首个多草本植物萃取工程，Felda 农业公司则侧重于生物学的培养和克隆技术，并将投资兴建一座价值2500万林吉特的生物技术实验室。Stevian 生物技术公司也将参与研究和发展，并建造健康性和营养型并存的天然香料生产基地。除了这些公司以外，这个技术园区还将与生物技术企业如MHC和UiTM的Chemical Engineering Pilot Plant（CEPP）进行战略性合作。CEPP将建造@enstek内最大的专业性草药产品萃取和化学加工研究生产中心，同时这也是仅次于日本的世界上最大的生糖加工中心。
Malaysia Going After The Pearl Of Biotech Industry
Being in the mega biodiversity league with 12 other nations has not made Malaysia＇s achievement in biotechnology something to crow about．
While countries with advance biotechnology have long been in the high end of the industry and conquered the world with the extraction of herbs for better value， Malaysia is satisfied playing on the low side of the field．
Most of the biotech activities in the country still centre on turning the herbs into powder form and sold in capsule or blended into juice．
Chief Executive Officer of Tropical Botanics Malaysia Sdn Bhd， Dr Rajen M． is very philosophical in describing current state of Malaysia＇s biotechnology status．
He likens the scenario in the country to that of ″a sea shell on the shore．″
″We are excited by the sea shell with different colours． The real pearls are in the ocean． One pearl there could be worth more than all the sea shells －－ that is herbal extraction，″ he said．
WORLD HERBAL INDUSTRY
Dr Rajen said herbal extraction is the technology that Malaysia should undertake if it wanted to leapfrog into the world herbal industry worth US＄50 billion．
He said there are many herbs that are unique to Malaysia which is the fourth largest producer after China， India and Indonesia．
Uniquely too， Malaysia is the only place in the world where herbs used by the Chinese， Indian and Malay， like ″pegaga″ （centella asiatica） and ″kacip fatimah″ （labisia pothoina） have been ″cooked″ for the last 500 years．
Malaysia＇s other unique attribute was that its biodiversity was not only in the flora and fauna but also in the people．
Malaysia is the only place in the world where three races －－ the Malays， Chinese and Indians －－ live in one place．In doing research on a certain drug， for instance， in China， the medicine works for the Chinese but if the product is tested on other races， there might be some adverse reaction．So， by coming to Malaysia， you can do testing on the Malays who represent the Malay stock， the Chinese for those from mainland China， and so also the Indian．The local herbal industry is said to be worth between RM4 billion and RM5 billion a year．
The sector is expected to contribute about five percent to the Gross National Product by 2020．
BIOTECH BANDWAGON
The fact is， Malaysia＇s push to get onto the biotechnology bandwagon is not a recent effort．Over time， it evolved and to become the latest national project and new engine of growth for the country．The government is looking into various ways to accelerate the development of biotechnology like formulating specific laws and creating a new agency to manage the industry．
Many universities in the country had been or are putting their academic infrastructure in place to meet the challenges of the biotech development．
Besides， various physical infrastructure like the BioValley are being put in place as a hub of biotech companies and research institutions to carry out their activities．
The project， similar to the country＇s Multimedia Super Corridor （MSC）， may provide incentives currently offered by the United States， Europe， China， India and Singapore．
Science， Technology and Innovation Minister Datuk Seri Dr Jamaludin Jarjis said the perks might include tax incentives and pioneer status．
The task of providing infrastructure for the industry was well complemented by the private sector which has full faith in the potential of the industry．
One private sector project is ＠enstek， an integrated township in Negeri Sembilan， being developed by TH－NSTC Sdn Bhd．
HOTBED FOR BIOTECH
The entire township， covering an area of more than 2，000 hectares， will be the industrial and technological hub which will function as a hotbed for high technology －－ non－pollutant industries encompassing biotechnology， information technology， advance manufacturing technology and other related technology．
Chief Executive Officer of TH Properties， Syed Mohamed Syed Ibrahim， explained the reason behind the company＇s drive in choosing the biotech sector as its industry partner．
″．．．simply because we feel that this industry has the potential to contribute significantly to the economic growth of the country，″ he said．
Three companies －－ Tropical Botanics， Felda Agricultural Services Sdn Bhd and Stevian Biotechnology Corporation Sdn Bhd． －－ are already in the techpark．
Tropical Botanics would be operating Malaysia＇s first multi－herb extraction plant there while Felda Agricultural， which is involved in tissue culture and cloning， would be opening a RM25－million biotech laboratory in April next year．
Stevian Biotechnology Corporation is involved in research and development， and manufacturing natural sweeteners with functional， sensorial as well a health and nutritional properties．
It＇s plant at ＠enstek will be the largest ″saccharides sweetener－centric″ operating outside Japan．
Besides these companies， the techpark also has strategic collaboration with biotechnology partners in the likes of MHC and Chemical Engineering Pilot Plant （CEPP） of UiTM．
CEPP would set up the largest research and development （R＆D） centre in ＠enstek specialising in the extraction and chemical processes of herbal products．
With all the facilities on the line， Malaysia should be poised to enjoy the pearl of biotechnology from the ocean of the country＇s resources．